    Habib Dable | Bayer AG | ZoomInfo.com


Habib J Dable - Madison, NJ | Intelius



























Sign In



We found Habib J Dable in Madison, NJ


Habib J Dable

                                                                           Intelius found that Habib J Dable  is  a male between 50 and 50 years old from Madison, NJ.  We have connected them to
                5 addresses,
                2 phones,
                and 1 relative or associate.
         






Get Report Now

Age

Habib J Dable is in his 50s

Habib Has Lived In

Madison, NJ
Berkeley, CA
Chapel Hill, NC

Habib's Relatives

Hiroko Dable







Habib J Dable



GenderMale



Professional Status
Evp, Global Head Specialty Medicine at Bayer AG



Get Report Now










Want to know more about Habib? Get a comprehensive background report, find full phone numbers, and other contact information when available, all from billions of available public records.
            Continue below for more details about Habib, or use our people search engine to find others.
Get Background Check on Habib J Dable
Get a Criminal Check on Habib J Dable
Get a Public Record Report on Habib J Dable
Get a People Search Report on Habib J Dable


Habib J Dable's Contact Information
Known Cities Lived In
Find out where Habib J Dable has lived as well as Habib J Dable's phone numbers and email addresses.




Habib J Dable Has Lived in 3 States
New Jersey Address for Habib J Dable


15 G******* A** 

Madison, NJ


Has Lived In

Madison, NJ
Berkeley, CA


Get Full Address Report










Phone Numbers Associated with Habib J Dable

(919) ***-**** - Madison, NJ 
(510) ***-**** - Oakland, CA 


Get Full Phone Report



Email Addresses Associated with Habib J Dable



Get Email Report




Habib J Dable's Education Information
Known Schools Attended
Learn about Habib J Dable's academic history.  Find out which schools Habib J Dable attended, the dates attended as well as the degrees Habib J Dable received.
            The following data is not guaranteed for accuracy and should not be used for employment, insurance, credit eligibility, or for any other purpose covered under the Fair Credit Reporting Act.


Habib J Dable Has Attended 2 Schools
Stanford University Graduate School of Business 2007 – 2007               Habib J Dable has a Stanford Executive Program in Stanford Executive Program               
University of New Brunswick               1992 – 1994                              


Habib J Dable's Professional Information
Information regarding Habib J Dable's professional history.  Find out previous places Habib J Dable has worked as well as dates employed.
            The following data is not guaranteed for accuracy and should not be used for employment, insurance, credit eligibility, or for any other purpose covered under the Fair Credit Reporting Act.


Habib J Dable Has Worked at 9 Places
Company: Bayer AG
               Title: Evp, Global Head Specialty Medicine
Company: Bayer AG
               Title: Vp Ophthalmology & Global Launch Team Head - Eylea?
Habib J Dable's Experience
Title: Evp, Global Head Specialty Medicine
               Company: Bayer AG
Job Details

Title: Vp Ophthalmology & Global Launch Team Head - Eylea?
               Company: Bayer AG
Job Details

Additional Professional Information on Habib J Dable

 See Habib J Dable's LinkedIn Profile



Habib J Dable's Social Network and Potential Email Matches
Find out potential social network profiles and potential email usernamed for Habib J Dable


Habib J Dable's known Social Networks And Potential Email Matches

Find all of Habib J Dable's Social Network Profiles

Get Full Report

Search Social Networks
Including Facebook, LinkedIn, MySpace, Google, Twitter, Yahoo, Jigsaw, ZoomInfo and more



Potential Email Matches
Habib Dable
Username Matches

                  HabibDable
                  DableHabib
                  Habib.Dable
                  Dable.Habib
                  Habib_Dable
                  Dable_Habib
                  Habib-Dable
                  Dable-Habib
                  HDable
               


Popular Email Services

@gmail.com
@aol.com
@yahoo.com
@comcast.net
@hotmail.com
@msn.com
@rocketmail.com
@att.net
@sbcglobal.net
@ymail.com
@facebook.com
@mail.com
@bellsouth.net
@live.com
@earthlink.net
@cox.net
@prodigy.net
@me.com
@peoplepc.com
@juno.com
@rediffmail.com
@mindspring.com
@comcast.com
@charter.net
@outlook.com




All trademarks, product names, company names or logos on this page are the property of their respective owners.
Related People Searches
H Dable







         Intelius is a leading provider of public data about people and their connections to others. Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the Fair Credit Reporting Act (FCRA). This site should not be used to determine an individual’s eligibility for credit, insurance, employment, housing or any other purpose covered by the FCRA. For employment or tenant screening services, please visit our partner Talentwise.
      

About Us
Site Map
About Our Reports
Blog
Help
Contact Us

© 2003 – 2017 PeopleConnect, Inc. d/b/a Intelius. All Rights Reserved.
         Privacy Policy - UPDATED
Terms of Service - UPDATED






What is the FCRA?
The Fair Credit Reporting Act ("FCRA") is a federal law that promotes the accuracy, fairness and privacy of information in the files of consumer reporting agencies.
Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the FCRA. Intelius reports cannot be used for background checks related to consumer credit, insurance, employment, housing or any other purpose
                  prohibited under the FCRA.
You may not use any information obtained from Intelius for any purpose covered by the FCRA.
Find out more about the FCRA here.













Habib J. Dable: Executive Profile & Biography - Bloomberg










































  





















































































July 28, 2017 8:22 AM ET
Biotechnology

Company Overview of Acceleron Pharma Inc.



SnapshotPeople 




OverviewBoard MembersCommittees



Executive Profile
Habib J. Dable  President, CEO & Director, Acceleron Pharma Inc.AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 3 different industries.See Board Relationships48$11,195,557As of Fiscal Year 2016
Background

		Mr. Habib J. Dable has been the Chief Executive Officer and President at Acceleron Pharma Inc. since December 1, 2016. Mr. Dable served as President of Bayer HealthCare Pharmaceuticals Inc. since October 1, 2015. Mr. Dable served as the President of Bayer Pharmaceuticals US at Bayer Corporation October since 2015. He served as Global Head of Specialty Medicine for Bayer HealthCare Pharmaceuticals from 2013 to 2015 and was responsible for overseeing four therapeutic areas ... for Bayer HealthCare Pharmaceuticals – hematology, oncology, ophthalmology and neurology. He began his career at Bayer in 1994 as a Sales Representative in Canada, where he later and moved on to various sales and marketing roles with increasing management responsibility. He served for two years at Bayer HealthCare’s office in Osaka, Japan as Head of Strategic Planning and Director of International Sales and Marketing. He served as Vice President and Regional Business Unit Head and was responsible for Latin America, Canada, Asia Pacific and Japan. From 2008 to 2012, he headed Bayer’s global therapeutic area team for Neurology / Ophthalmology and Vice President for Ophthalmology and headed the global launch team for EYLEA® (aflibercept). He has been a Director of Acceleron Pharma Inc. since December 1, 2016. He serves as member of the Board of Directors and Health Section Governing Board of the Biotechnology Innovation Organization (BIO). Mr. Dable earned Bachelor's degree of Business Administration and Master’s of Business Administration from the University of New Brunswick in Canada.Read Full Background




Corporate Headquarters
128 Sidney StreetCambridge, Massachusetts 02139United StatesPhone: 617-649-9200Fax: 617-649-9988
Board Members Memberships
2016-PresentPresident, CEO & DirectorAcceleron Pharma Inc.
Education
MBA University Of New Brunswick, FrederictonBBA University Of New Brunswick, Fredericton
Other Affiliations
Bayer CorporationBayer HealthCare Pharmaceuticals Inc.University Of New Brunswick, Fredericton


Annual Compensation
Salary$45,833Bonus$350,000Total Annual Compensation$395,833
Stocks Options
Restricted Stock Awards$2,200,512All Other Compensation$21,932Unexercisable Options$400,000Total Number of Options$400,000
Total Compensation
Total Annual Cash Compensation$472,765Total Short Term Compensation$395,833Other Long Term Compensation$2,222,444Total Calculated Compensation$11,195,557




Request Profile Update
















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



COMPETITOR COMPENSATIONThere is no Competitor Compensation data available.










Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact Acceleron Pharma Inc., please visit .  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close




























Habib Dable, Acceleron Pharma Inc: Profile & Biography - Bloomberg


































































  























Feedback





Habib Dable

President/CEO,
Acceleron Pharma Inc






Career History




President/CEO
Acceleron Pharma Inc, 12/2016-PRESENT


President
Bayer Healthcare Pharmaceuticals LLC, 10/2015-12/2016


Global Head:Specialty Medicine
Bayer Healthcare Pharmaceuticals LLC, 2013-9/2015



Bayer Healthcare Pharmaceuticals LLC, 1994-UNKNOWN


Show More









Website:
www.acceleronpharma.com






Corporate Information
Address:

128 Sidney Street
Cambridge, MA 02139
United States


Phone:
1-617-649-9200


Fax:
1-617-649-9988


Web url:
www.acceleronpharma.com











From The Web












Personal Information



Education



University of New Brunswick
Master's Degree, Business Administration


University of New Brunswick
Bachelor's Degree








Memberships



Board Memberships




Acceleron Pharma Inc


Board Member, 12/2016-PRESENT









Sponsored Financial Commentaries







More From The Web


















Home


News


Top Headlines
Most Popular
Exclusive
Law
Entrepreneurs
Leaders
Economy
Environment
Science
Sports
Markets Magazine
Pursuits Magazine
Bloomberg Visual Data
Bloomberg Best (and Worst)
For comments or complaints about news coverage click here


Regions
U.S.
China
Europe
Asia
U.K. & Ireland
Australia & New Zealand
Canada
India & Pakistan
Japan
Africa
Eastern Europe
Latin America
Middle East
Markets
Commodities
Currencies
Bonds
Stocks
Energy Markets
Municipal Bonds
Emerging Markets
Funds
Islamic Finance
Industries
Energy
Technology
Real Estate
Finance
Health Care
Transportation
Insurance
Retail
Media
Manufacturing




Quick


Market Data


Stocks
Stock Futures
World Indexes
Americas
Europe, Middle East, & Africa
Asia-Pacific
Gainers & Losers
Earnings Calendar
Industry Leaders
Currencies
Americas
Europe, Middle East, & Africa
Asia-Pacific
Foreign Exchange Cross Rates
FX Fixings
Currency Converter
Forex Trading Videos
Commodities
Energy Prices
Metals Prices
Agricultural Prices


Rates & Bonds
US Treasuries
UK Gilts
Germany Bunds
Japan Bonds
Australia Bonds
Bloomberg Bond Indexes
Corporate Bonds
Consumer Rates
Economic Calendar
Watchlist
European Debt Crisis
Symbol Search
The Market Now




Personal Finance


Top Headlines
Saving & Investing
Real Estate
Retirement Planning
Financial Advisers
Taxes
Blog: Ventured & Gained
Real Cost Of
Money Gallery
Calculators
Watchlist (Portfolio Tracker)




Tech


Top Headlines
Social Media
Mobile & Wireless
Web
Enterprise Tech
TV, Games & Movies
Apple
Tech Deals
Global Tech
Slideshows
Videos




U.S. Politics


Sustainability


Top Headlines
Energy
Corporate Sustainability
Policy
Natural Resources
Health & Population
Slideshows
Videos
Blog: The Grid




Luxury


Top Headlines
Autos
Billionaires
Living
Property
Travel
Well Spent
Loot Blog
Pursuits Magazine
Videos




TV


Live TV
Channel Finder
Personalities
Apple TV
iPad App
Schedule
U.S.
Asia
Europe


Shows
Surveillance
Market Makers
Lunch Money
Street Smart
Bloomberg West
Game Changers




Video


Must See
Latest
Live TV
Shows
Playlist




Radio


Live Radio
Shows
Schedule
Personalities
Podcasts
Bloomberg Brief
Featured Podcasts and New Shows
Bloomberg View
Masters in Business
First Word
Surveillance
Bloomberg Advantage
In the Loop
Bloomberg Law
Taking Stock
Bloomberg Best
More Podcasts




Blogs


Global Tech
The Grid
Loot
The Market Now
Political Capital
Tech Deals
Ventured and Gained




Opinion




My Saved



Registration



Sign In



Bloomberg.com



Businessweek.com



Company



About
Blog
Careers
Diversity & Inclusion
News Mission
Philanthropy & Engagement
Press Room
Procurement
Sustainability




Products



Financial Products
Bloomberg Professional Service
Bloomberg Anywhere
Bloomberg Tradebook
Bloomberg Briefs
Bloomberg Indexes
Bloomberg SEF
Service Center
Customer Support
Enterprise Products
Enterprise Solutions
Trading Solutions
Industry Products
Bloomberg BNA
Bloomberg Government
Bloomberg Law
Bloomberg Link
Bloomberg New Energy Finance
Bloomberg Sports
Content Licensing




Bloomberg Anywhere



Mobile Apps



Bloomberg Visual Data



































XLRN Habib J. Dable Insider Trades for Acceleron Pharma Inc.


































Bulletin






Investor Alert







New York Markets Open in:



Market Snapshot
Analyst Ratings


















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































Acceleron Pharma Inc.

                  NASDAQ: XLRN
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

Acceleron Pharma Inc.



After Hours
 --Quotes are delayed by 20 min
Jul 27, 2017, 4:58 p.m.


XLRN

/quotes/zigman/20500114/composite


$
31.48




Change

-0.0038
-0.01%

Volume
Volume 10,366
Quotes are delayed by 20 min








/quotes/zigman/20500114/composite
Previous close

$
			32.12
		


$
				31.48
			
Change

-0.64
-1.99%





Day low
Day high
$30.78
$32.48










52 week low
52 week high

            $23.07
        

            $41.69
        


















Insider Activity


Individual




Habib J. Dable



Mr. Habib J. Dable is President at Bayer HealthCare Pharmaceuticals, Inc. He is on the Board of Directors at Acceleron Pharma, Inc. He received his undergraduate degree from the University of New Brunswick and an MBA from the University of New Brunswick.



Transactions


Date
Shares
Transaction
Value





12/01/2016
62,800


 
Award at $0 per share.


0





        Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
    











            Officers and Executives
        





Mr. Habib J. Dable 
President, Chief Executive Officer & Director




Mr. Kevin F. McLaughlin 
Chief Financial Officer, Treasurer & Senior VP




Dr. Matthew L. Sherman 
Chief Medical Officer & Executive Vice President




Dr. Ravindra  Kumar 
Chief Scientific Officer & Senior Vice President




Mr. Christopher  Rovaldi 
Vice President-Program Management




Mr. Todd  James 
Head-Investor Relations & Corporate Communications




Dr. John D. Quisel 
Secretary, Senior Vice President & General Counsel




Dr. Francois  Nader 
Chairman




Mr. Thomas A. McCourt 
Independent Director




Mr. Terrence C. Kearney 
Independent Director




Dr. Tom  Maniatis 
Independent Director




Mr. Terrance G. McGuire 
Independent Director




Dr. George S. Golumbeski 
Independent Director




Mr. Joseph S. Zakrzewski 
Independent Director




Mr. Richard F. Pops 
Lead Independent Director




Ms. Jean M. George 
Independent Director









Trending Tickers


/quotes/zigman/17636479/composite VUZI+15.60%


/quotes/zigman/237947/composite JCP-5.83%


/quotes/zigman/59392505/composite NUGT-2.93%


/quotes/zigman/59386294/composite JNUG-5.94%


/quotes/zigman/65801738/composite TLT+1.11%


X




Powered by














Log In




8:22 AM EDT
July 28, 2017


/marketstate/country/us
New York

	Pre


/marketstate/country/uk
London

	Open


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
8:22aAlexion Pharmaceuticals upgraded to outperform from perform at Oppenheimer
8:21aMerck says it issued conservative guidance due to recovery from cyber attack in late June
8:19aNuVasive downgraded to neutral from outperform at Baird
8:19aA provocative new analysis suggests you don’t have to take all your antibiotics after all
8:18aWhat Donald Trump’s battle of wills with Jeff Sessions teaches you about a difficult boss
8:18aScaramucci says Trump’s love of cheeseburgers shows he’s not an elitist — 5 ways rich people act humble
8:17aTeekay Offshore Partners downgraded to market perform from outperform at Raymond James
8:17a5 weird things I found out about America in my first 24 hours 
8:17aElectronic Arts shares slide 3% as outlook falls short
8:16aIntel stock price target raised to $41 from $39 at Stifel Nicolaus
8:15aUPS stock price target raised to $103 from $100 at Stifel Nicolaus
8:15aMeet the ‘Hamilton’ actors who fly cross-country and play up to 18 roles in the hit show
8:15aExpedia stock price target raised to $160 from $135 at Stifel Nicolaus
8:14aAmazon stock price target raised to $1,100 from $1,075 at Stifel Nicolaus
8:13aHawaiian Holdings upgraded to hold from sell at Stifel Nicolaus
8:13aStarbucks stock price target cut to $58 from $66 at Stifel Nicolaus
8:13aTTM Technologies downgraded to hold from buy at Stifel Nicolaus
8:12aThis fund strategist says there’s at least one way companies can survive Amazon’s onslaught
8:12aStarbucks downgraded to hold from buy at Stifel Nicolaus
8:12aA quarter of S&P 500’s 2017 climb due to five stocks (yes, those five)
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,796.55

+85.54
+0.39%





nasdaq

/quotes/zigman/12633936/realtime
6,382.19

-40.56
-0.63%





s&p 500

/quotes/zigman/3870025/realtime
2,475.42

-2.41
-0.10%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15































































Habib J. Dable - Executive Bio, Compensation History, and Contacts - Equilar Atlas










 

















Log in | Sign up








x

 






As Featured In



















Habib J. Dable
President, Chief Executive Officer, and Director at Acceleron Pharma Inc.


View Full Profile
Are you Habib J. Dable? Claim your profile


 


Sign up for Equilar Atlas and view Habib J. Dable's full profile. 
With Equilar Atlas, you can:



IDENTIFY corporate executives in Habib J. Dable's  network and community.
												FOLLOW changes in Habib J. Dable's employment and money-in-motion.
												CONNECT with Habib J. Dable through your network of contacts.
												








Habib J. Dable's Executive Work History


Current


President, Chief Executive Officer, and Director, 
Acceleron Pharma Inc.


Past
To view Habib J. Dable's complete executive work history, sign up now
Age
47

 
 


Habib J. Dable's Biography



Habib J. Dable has served as our Chief Executive Officer and President and a member of our Board of Directors since December 2016. Mr. Dable is a seasoned pharmaceutical executive, with experience in maximizing the potential of new therapies and successfully implementing innovative U.S. and global product launches. Since 1994, Mr. Dable has served in roles of increasing responsibility at Bayer AG, serving since October 2015 as the President of Pharmaceuticals for Bayer in the U.S. From 2013 to 2015, Mr. Dable served as the Executive Vice President and Global Head of Specialty Medicine for Bayer HealthCare Pharmaceuticals, and from 2010 to 201 ...
(Read More)

			Habib J. Dable has served as our Chief Executive Officer and President and a member of our Board of Directors since December 2016. Mr. Dable is a seasoned pharmaceutical executive, with experience in maximizing the potential of new therapies and successfully implementing innovative U.S. and global product launches. Since 1994, Mr. Dable has served in roles of increasing responsibility at Bayer AG, serving since October 2015 as the President of Pharmaceuticals for Bayer in the U.S. From 2013 to 2015, Mr. Dable served as the Executive Vice President and Global Head of Specialty Medicine for Bayer HealthCare Pharmaceuticals, and from 2010 to 2012, he was the Vice President of Ophthalmology & Global Launch Team Head for EYLEA. Mr. Dable earned both Bachelor's and Master's degrees of Business Administration from the University of New Brunswick in Canada. We believe Mr. Dable's executive leadership experience and industry knowledge qualify him to serve as a member of our Board of Directors.
		
Source: Acceleron Pharma Inc. on 04/13/2017
		
	

 






Sign up for Equilar Atlas and view Habib J. Dable's full profile. 



												By accessing Equilar Atlas, you can view bios, network, salary and wealth events
												of industry-leading executives like Habib J. Dable. More specifically, you'll be able to:
												

IDENTIFY corporate executives in Habib J. Dable's  network and community.
												FOLLOW changes in Habib J. Dable's employment and money-in-motion.
												CONNECT with Habib J. Dable through your network of conections.
												




View Full Profile


 








Search for over 360,000 executive profiles.





/bio



													Example: Habib J. Dable


















Habib J. Dable's Connections (14)





Sign up now to view Habib J. Dable's 14 connections »









Terrance G. McGuire
Board Member, Ironwood Pharmaceuticals, Inc.









Francois Nader
Chairman of the Board, Acceleron Pharma Inc.









Terrence C. Kearney
Board Member, Vertex Pharmaceuticals Incorporated









Richard F. Pops
Chairman of the Board and Chief Executive Officer, Alkermes









Joseph S. Zakrzewski
Board Member, Insulet Corporation









Matthew L. Sherman
Executive Vice President and Chief Medical Officer, Acceleron Pharma Inc.









Tom Maniatis
Board Member, Acceleron Pharma Inc.









Ravindra Kumar
Senior Vice President and Chief Scientific Officer, Acceleron Pharma Inc.









Steven D. Ertel
Executive Vice President and Chief Operating Officer, Acceleron Pharma Inc.









John D. Quisel
Senior Vice President, General Counsel and Secretary, Acceleron Pharma Inc.








Popular Profiles






														Sign up now to view more executive profiles »
														









Thomas J. Lynch
Executive Chairman, TE Connectivity Ltd.









John J. Kita
EVP and CFO, A. O. Smith









Carl G. Annessa
EVP and COO, Hornbeck Offshore Services, Inc.









Elon R. Musk
CEO and Chairman, Tesla









Michael C. Montgomery
Board Member, NMI Holdings, Inc.












×

Claim Your Profile Coming Soon
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.

Done


Thank you for your interest.
Ok






			Browse executive profiles:
			
				 A
			
				 B
			
				 C
			
				 D
			
				 E
			
				 F
			
				 G
			
				 H
			
				 I
			
				 J
			
				 K
			
				 L
			
				 M
			
				 N
			
				 O
			
				 P
			
				 Q
			
				 R
			
				 S
			
				 T
			
				 U
			
				 V
			
				 W
			
				 X
			
				 Y
			
				 Z



Equilar Homepage
Equilar Atlas
Equilar Insight
Equilar BoardEdge
Equilar Engage
Research Services
Knowledge Network
About Us
Login

ï¿½ 2017 Equilar All Rights Reserved. Privacy Policy
1100 Marshall Street, Redwood City, CA 94063 | Phone (650) 241-6600 | Fax (650) 701-0993


































 



 Bayer Appoints Habib Dable to Lead U.S. Pharmaceuticals Business 
         










    










 













 











 



















Bayer Appoints Habib Dable to Lead U.S. Pharmaceuticals Business
        																																												
              

          Philip Blake becomes Head of Region Americas for Bayer HealthCare Pharmaceuticals and continues to head U.S. corporate functions as Senior Bayer Representative U.S.A.
        
















 News provided by
Bayer  
Oct 01, 2015, 10:00 ET









 Share this article



























































WHIPPANY, N.J., Oct. 1, 2015 /PRNewswire/ -- Bayer today announced the appointment of Habib Dable as president of Bayer HealthCare Pharmaceuticals, the U.S.-based division of the global company's pharmaceutical business. Dable will report to Philip Blake, who will now assume the role of head of region Americas for Bayer HealthCare Pharmaceuticals and continue leading U.S. corporate functions as senior Bayer representative (SBR) in the United States, a position he has held since 2012. 













                Habib Dable, president of Bayer HealthCare Pharmaceuticals in the U.S.
              

 
 



"Habib Dable is a highly respected leader at Bayer, and I'm thrilled to have someone with such a wealth of experience step in to lead the company's largest pharmaceuticals market worldwide," said Blake. "Having spent more than two decades at Bayer in a range of key roles with increasing management responsibility, Habib will be a critical asset as we look to build on our positive momentum in the U.S. to create long-term growth."
Previously, Dable was global head of specialty medicine for Bayer HealthCare Pharmaceuticals, a role he held since 2013 and in which was responsible for overseeing four therapeutic areas for the company – hematology, oncology, ophthalmology, and neurology. He began his career at Bayer in 1994 as a sales representative and moved on to hold a number of senior roles in Canada, Japan and the U.S., focusing on strategic planning, sales management, and global product marketing including successfully leading global product launches. 
Dable earned a Masters of Business Administration from the University of New Brunswick in Canada, where he also completed his undergraduate study. He is married with two children, and resides in New Jersey.
About Bayer HealthCare Pharmaceuticals Inc. Bayer HealthCare Pharmaceuticals Inc. is the U.S.-based pharmaceuticals business of Bayer HealthCare LLC, a subsidiary of Bayer AG. Bayer HealthCare is one of the world's leading, innovative companies in the healthcare and medical products industry, and combines the activities of the Animal Health, Consumer Care, Medical Care, and Pharmaceuticals divisions. As a specialty pharmaceutical company, Bayer HealthCare provides products for general medicine, hematology, neurology, oncology and women's healthcare. The company's aim is to discover and manufacture products that will improve human health worldwide by diagnosing, preventing and treating diseases.
About Bayer CorporationBayer: Science For A Better LifeBayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2014, the Group employed around 119,000 people and had sales of EUR 42.2 billion. Capital expenditures amounted to EUR 2.5 billion, R&D expenses to EUR 3.6 billion. These figures include those for the high-tech polymers business, which is to be floated on the stock market as Covestro by mid-2016 at the latest. For more information, go to www.bayer.us 
Social Media Channels:Facebook: facebook.com/BayerTwitter: twitter.com/BayerUSYouTube: youtube.com/BayerChannel  #ScienceForABetterLife
Bayer® and the Bayer Cross® are registered trademarks of Bayer. 
Forward-Looking Statements This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports, which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
Photo - http://photos.prnewswire.com/prnh/20150930/272795 Logo - http://photos.prnewswire.com/prnh/20140312/NY79226LOGO 
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/bayer-appoints-habib-dable-to-lead-us-pharmaceuticals-business-300152535.html
SOURCE  Bayer  Related Links

http://www.bayer.com




 





















Oct 22, 2015, 09:10 ET
Preview: Bayer to Present Pulmonary Arterial Hypertension Data at American College of Chest Physicians (ACCP) Annual Meeting




















Sep 28, 2015, 14:18 ET
Preview: Bayer Presents Country Music Star Luke Bryan on Fall Farm Tour








My News


  Release contains wide tables.	  View fullscreen.






 Also from this source




 











Jul 24, 2017, 10:03 ET
                                  				                                                                                     
                              2017 Bayer Bee Care Community Leadership Award Winners Honored...








 











Jul 14, 2017, 08:15 ET
                                  				                                                                                     
                              Bayer and White Ribbon Alliance Partnership Reaches 1,200 Women...





 Explore
 More news releases in similar topics

  Health Care & Hospitals
  Medical Pharmaceuticals
  Pharmaceuticals
Personnel Announcements








 You just read:
Bayer Appoints Habib Dable to Lead U.S. Pharmaceuticals Business


 News provided by
Bayer  
Oct 01, 2015, 10:00 ET








 Share this article









































 











Looking to send a news release with PR Newswire?
Take advantage of the world's leading distribution platform.
Sign up to get started
Request more information
Have an account? Log In



















Search











Searching for your content...









Advanced Search












































 











Habib J. Dable - Executive Bio, Compensation History, and Contacts - Equilar Atlas










 

















Log in | Sign up








x

 






As Featured In



















Habib J. Dable
President, Chief Executive Officer, and Director at Acceleron Pharma Inc.


View Full Profile
Are you Habib J. Dable? Claim your profile


 


Sign up for Equilar Atlas and view Habib J. Dable's full profile. 
With Equilar Atlas, you can:



IDENTIFY corporate executives in Habib J. Dable's  network and community.
												FOLLOW changes in Habib J. Dable's employment and money-in-motion.
												CONNECT with Habib J. Dable through your network of contacts.
												








Habib J. Dable's Executive Work History


Current


President, Chief Executive Officer, and Director, 
Acceleron Pharma Inc.


Past
To view Habib J. Dable's complete executive work history, sign up now
Age
47

 
 


Habib J. Dable's Biography



Habib J. Dable has served as our Chief Executive Officer and President and a member of our Board of Directors since December 2016. Mr. Dable is a seasoned pharmaceutical executive, with experience in maximizing the potential of new therapies and successfully implementing innovative U.S. and global product launches. Since 1994, Mr. Dable has served in roles of increasing responsibility at Bayer AG, serving since October 2015 as the President of Pharmaceuticals for Bayer in the U.S. From 2013 to 2015, Mr. Dable served as the Executive Vice President and Global Head of Specialty Medicine for Bayer HealthCare Pharmaceuticals, and from 2010 to 201 ...
(Read More)

			Habib J. Dable has served as our Chief Executive Officer and President and a member of our Board of Directors since December 2016. Mr. Dable is a seasoned pharmaceutical executive, with experience in maximizing the potential of new therapies and successfully implementing innovative U.S. and global product launches. Since 1994, Mr. Dable has served in roles of increasing responsibility at Bayer AG, serving since October 2015 as the President of Pharmaceuticals for Bayer in the U.S. From 2013 to 2015, Mr. Dable served as the Executive Vice President and Global Head of Specialty Medicine for Bayer HealthCare Pharmaceuticals, and from 2010 to 2012, he was the Vice President of Ophthalmology & Global Launch Team Head for EYLEA. Mr. Dable earned both Bachelor's and Master's degrees of Business Administration from the University of New Brunswick in Canada. We believe Mr. Dable's executive leadership experience and industry knowledge qualify him to serve as a member of our Board of Directors.
		
Source: Acceleron Pharma Inc. on 04/13/2017
		
	

 






Sign up for Equilar Atlas and view Habib J. Dable's full profile. 



												By accessing Equilar Atlas, you can view bios, network, salary and wealth events
												of industry-leading executives like Habib J. Dable. More specifically, you'll be able to:
												

IDENTIFY corporate executives in Habib J. Dable's  network and community.
												FOLLOW changes in Habib J. Dable's employment and money-in-motion.
												CONNECT with Habib J. Dable through your network of conections.
												




View Full Profile


 








Search for over 360,000 executive profiles.





/bio



													Example: Habib J. Dable


















Habib J. Dable's Connections (14)





Sign up now to view Habib J. Dable's 14 connections »









Terrance G. McGuire
Board Member, Ironwood Pharmaceuticals, Inc.









Francois Nader
Chairman of the Board, Acceleron Pharma Inc.









Terrence C. Kearney
Board Member, Vertex Pharmaceuticals Incorporated









Richard F. Pops
Chairman of the Board and Chief Executive Officer, Alkermes









Joseph S. Zakrzewski
Board Member, Insulet Corporation









Matthew L. Sherman
Executive Vice President and Chief Medical Officer, Acceleron Pharma Inc.









Tom Maniatis
Board Member, Acceleron Pharma Inc.









Ravindra Kumar
Senior Vice President and Chief Scientific Officer, Acceleron Pharma Inc.









Steven D. Ertel
Executive Vice President and Chief Operating Officer, Acceleron Pharma Inc.









John D. Quisel
Senior Vice President, General Counsel and Secretary, Acceleron Pharma Inc.








Popular Profiles






														Sign up now to view more executive profiles »
														









Thomas J. Lynch
Executive Chairman, TE Connectivity Ltd.









John J. Kita
EVP and CFO, A. O. Smith









Carl G. Annessa
EVP and COO, Hornbeck Offshore Services, Inc.









Elon R. Musk
CEO and Chairman, Tesla









Michael C. Montgomery
Board Member, NMI Holdings, Inc.












×

Claim Your Profile Coming Soon
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.

Done


Thank you for your interest.
Ok






			Browse executive profiles:
			
				 A
			
				 B
			
				 C
			
				 D
			
				 E
			
				 F
			
				 G
			
				 H
			
				 I
			
				 J
			
				 K
			
				 L
			
				 M
			
				 N
			
				 O
			
				 P
			
				 Q
			
				 R
			
				 S
			
				 T
			
				 U
			
				 V
			
				 W
			
				 X
			
				 Y
			
				 Z



Equilar Homepage
Equilar Atlas
Equilar Insight
Equilar BoardEdge
Equilar Engage
Research Services
Knowledge Network
About Us
Login

ï¿½ 2017 Equilar All Rights Reserved. Privacy Policy
1100 Marshall Street, Redwood City, CA 94063 | Phone (650) 241-6600 | Fax (650) 701-0993













 






Habib  Dable, President, Bayer HealthCare


























&timesJavascript is disabled
























Market Profiles



Login
Sign up



Login


Sign up








 







 Edit

Person













Habib  Dable



President
at
Bayer HealthCare


Location: New York, NY





Add to My Lists

Claim

Share


Copy the following code on your page/blog


Suggested widget size



Mobile



Desktop









Habib  Dable



President
at
Bayer HealthCare


Location: New York, NY




Add to My Lists

Claim

Share


Copy the following code on your page/blog


Suggested widget size



Mobile



Desktop




Habib  Dable is President at Bayer Health Care. Previously, Dable was global head of specialty medicine for Bayer HealthCare Pharmaceuticals in which was responsible for overseeing four therapeutic areas for the company – hematology, oncology, ophthalmology, and neurology. He began his career at Bayer in 1994 as a sales representative and moved on to hold a number of senior roles in Canada, Japan and the U.S.
Dable earned a Masters of Business Administration from the University of New Brunswick in Canada, where he also completed his undergraduate study. He is married with two children, and resides in New Jersey.



1

Companies in Career





N/A

Related Markets





3

Colleagues





N/A

Related Investments








Alias
N/A



Industry
Pharmaceuticals




Tags
Pharmaceutical Industry, Product Launch, Ophthalmology, Oncology




Topics of Influence












Web Site







N/A



























Careers








Achievements








Investments








Related People






 Edit
View all 



Habib  DableCareer (3)






Oct-2015




Bayer HealthCare



President







Jan-2013 to Sep-2015




Bayer HealthCare



EVP, Global Head Specialty Medicine







Jan-2010 to Dec-2012




Bayer HealthCare



VP Ophthalmology & Global Launch Team Head - EYLEA®








Competencies










 Edit
View all 



Habib  DableEducation (2)






2007



Stanford University Graduate School of Business


Stanford Executive Program






1994



University of New Brunswick












 Edit



Habib  DableAchievements and Recognitions





Add Milestone


No milestones has been recorded for Habib  Dable






 Edit



Habib  DableLinks





Add Link


No links has been recorded for Habib  Dable









Habib  DableInvestments/Acquisitions





No investments has been recorded for Habib  Dable









Habib  DableInvestments Representing Others





No investment reps has been recorded for Habib  Dable








Habib  DableRelated People








Colleagues at Bayer HealthCare







Werner Baumann

Chairman
Apr-2015









Johannes Dietsch

Chief Financial Officer
Oct-2014









Spencer Rothschild

Director, Business Process Innovation













View all 



Habib  DableRecommended Market Profiles (8)








Telemedicine

10,000 or More employees
19 companies








Social Media Marketing (ChiefMartec.com)

5,000 - 10,000 employees
111 companies








Big Data Universe List of Lists

10,000 or More employees
533 companies








Aggregated Marketing Technology

10,000 or More employees
2650 companies








Shared Economy Landscape (Jeremiah Owyang)

10,000 or More employees
267 companies








Inside Sales Landscape

10,000 or More employees
650 companies


















